Sign in

NCT06807697Completed

Quality of Life Before and After Radiotherapy in Patients With Head and Neck Cancer

A Pilot Investigation of the Quality of Life Before and After Radiotherapy in Patients With Head and Neck Cancer

Source: ClinicalTrials.gov · Last updated 11 May 2025

Brief summary (registry, in English)

Worldwide, head and neck cancers (HNCs) are widespread (650,000 cases per year) and cause more than 330,000 deaths per year. Almost all cases, about 90%, are cancers of the oral cavity, oropharynx, and larynx. In conventional clinical practice, HNCs are treated primarily with radiation therapy (RT), often used in combination with surgery and/or chemotherapy. Like most anti-neoplastic therapies, RT carries significant adverse effects both acute and chronic. Both types of adverse effects have a significant impact on quality of life (QoL). The aim of the study is to examine the worsening of QoL in patients with HNC before and after cancer therapy and to assess the extent that each factor has in its worsening.

Status (registry)
Completed
Study type
Observational
Enrollment
22 (actual)
First submitted
29 Jan 2025
Start date
2 Jan 2025
Primary completion date
30 Apr 2025
Lead sponsor
University of Turin, Italy
NCT number
NCT06807697

What you commit to

  • Study type: Observational
  • Participants enrolled: 22
  • From 2 Jan 2025 to the primary completion date, 30 Apr 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • patients who had already undergone cancer therapies (excisional surgery or chemotherapy or radiation therapy) at the time of the first dental visit;

Other

  • patients with depression or social anxiety;
  • patients with language difficulties.

Who the study is looking for

  • patients between the ages of 18 and 75 years;
  • patients who presented at their first dental visit with a diagnosis of HNC.

Age in the registry: 18 years to 75 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
AOU Città della Salute e della Scienza
Coordinator of this site? Confirm its status
TorinoItalyUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.